标题
Evaluating The Impact Of The Orphan Drug Act’s Seven-Year Market Exclusivity Period
作者
关键词
-
出版物
HEALTH AFFAIRS
Volume 37, Issue 5, Pages 732-737
出版商
Health Affairs (Project Hope)
发表日期
2018-05-08
DOI
10.1377/hlthaff.2017.1179
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers
- (2017) Aaron S. Kesselheim et al. HEALTH AFFAIRS
- Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
- (2017) Aaron S. Kesselheim et al. PLOS MEDICINE
- History of Orphan Drug Regulation-United States and Beyond
- (2016) ME Haffner CLINICAL PHARMACOLOGY & THERAPEUTICS
- Generic Drug Approvals Since the 1984 Hatch-Waxman Act
- (2016) Ravi Gupta et al. JAMA Internal Medicine
- The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines
- (2015) Jing Luo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progress and Hurdles for Follow-on Biologics
- (2015) Ameet Sarpatwari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Patents at the Supreme Court
- (2013) C. S. Hemphill et al. SCIENCE
- Evergreening, patent challenges, and effective market life in pharmaceuticals
- (2012) C. Scott Hemphill et al. JOURNAL OF HEALTH ECONOMICS
- Use Patents, Carve-Outs, and Incentives — A New Battle in the Drug-Patent Wars
- (2012) Arti Rai NEW ENGLAND JOURNAL OF MEDICINE
- Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents
- (2012) Amy Kapczynski et al. PLoS One
- The Benefits From Giving Makers Of Conventional ‘Small Molecule’ Drugs Longer Exclusivity Over Clinical Trial Data
- (2011) Dana P. Goldman et al. HEALTH AFFAIRS
- Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer
- (2011) Aaron S. Kesselheim JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Empirical Review of Major Legislation Affecting Drug Development: Past Experiences, Effects, and Unintended Consequences
- (2011) AARON S. KESSELHEIM MILBANK QUARTERLY
- Balancing Innovation, Access, and Profits — Market Exclusivity for Biologics
- (2009) Alfred B. Engelberg et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More